Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing unusual skin, eye, or hair issues can help diagnose immune system disorders early, especially in children.

A small 3D skin model helps study how immune cells move in the skin.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Neoplasms hide in hair follicles to avoid the immune system.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

New vaccine technologies are improving global health by making vaccines more effective and long-lasting.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Innovative methods are reducing animal testing and improving biomedical research.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Six months after COVID-19, most patients still had autoantibodies.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Age-related immune changes significantly affect disease development in other systems.